Data is not available at this time.
Nuance Communications, Inc. operates in the software application sector, specializing in conversational and cognitive AI solutions that enhance productivity and security across industries. The company’s core revenue model is driven by its Healthcare and Enterprise segments, which offer AI-powered clinical documentation, customer engagement, and security solutions. Its Healthcare segment, a key growth driver, provides cloud-based speech recognition and clinical language understanding tools, such as Dragon Medical One, which streamline medical documentation and reimbursement processes. The Enterprise segment leverages AI for automated customer service solutions, serving sectors like financial services, telecommunications, and retail. Nuance differentiates itself through deep domain expertise in voice and natural language processing, positioning it as a leader in AI-driven workflow optimization. The company’s acquisition by Microsoft in 2022 further strengthens its market position, integrating its AI capabilities into broader enterprise and cloud ecosystems. Nuance’s solutions are distributed globally via direct sales and reseller networks, ensuring broad market penetration. Its focus on healthcare digitization and AI-powered customer interactions aligns with growing demand for automation and efficiency, reinforcing its competitive edge in a rapidly evolving tech landscape.
Nuance reported revenue of EUR 1.36 billion for FY 2021, reflecting its strong market presence in AI-driven solutions. However, the company posted a net loss of EUR 17.4 million, with diluted EPS of -EUR 0.059, indicating profitability challenges despite robust top-line performance. Operating cash flow stood at EUR 247.6 million, demonstrating solid cash generation, while capital expenditures of EUR -56.5 million suggest disciplined investment in growth initiatives.
The company’s operating cash flow of EUR 247.6 million highlights its ability to convert revenue into cash, though net income remains pressured. Nuance’s capital efficiency is underscored by its focus on high-margin software solutions, particularly in healthcare, where recurring revenue models and scalability drive long-term earnings potential. The negative EPS, however, signals ongoing cost management challenges.
Nuance’s balance sheet shows EUR 187.3 million in cash and equivalents, providing liquidity, but total debt of EUR 977.7 million raises leverage concerns. The company’s financial health is supported by its acquisition by Microsoft, which likely alleviates near-term solvency risks and provides access to broader resources for debt management and strategic investments.
Nuance’s growth is tied to AI adoption in healthcare and enterprise sectors, with its solutions addressing critical efficiency needs. The company does not pay dividends, reinvesting cash flows into R&D and market expansion. Its integration into Microsoft’s ecosystem may accelerate growth through cross-selling and enhanced product offerings.
With a beta of 1.07, Nuance’s stock exhibits moderate volatility, reflecting its tech sector exposure. Market expectations are likely influenced by its acquisition by Microsoft, which may drive long-term value through synergies and expanded AI capabilities. The lack of a standalone market cap post-acquisition limits traditional valuation metrics.
Nuance’s strategic advantages lie in its AI expertise and Microsoft’s backing, positioning it for sustained growth in healthcare and enterprise automation. The outlook is positive, with integration into Microsoft’s cloud platform expected to enhance scalability and innovation. However, execution risks and competitive pressures in the AI space remain key considerations.
Company description, financial data from Deutsche Börse, and acquisition details from Microsoft.
show cash flow forecast
| Fiscal year | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |